Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

NCT03189537 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Acute Respiratory Infection
Common Cold
Flu
Viral Infection

Interventions

DRUG: Ingavirin (Imidazolyl Ethanamide Pentandioic Acid)
DRUG: Placebo oral capsule

Sponsor

Valenta Pharm JSC